BioPharm Insight provides the most comprehensive information to help you easily find the answers you need within the Biotechnology and Pharmaceutical industry.

It includes the entire drug discovery and development pipeline, approved drugs, licensing deals, pharmaceutical sales/projections, management contacts, and more.

• Detailed company profiles for over 4,100 Bio/Pharm companies
• Listings of 36,000 investigational drugs including development history, clinical trials, mechanisms, patents, molecular structures, and licensing deals
• 23,000+ approved drugs
• Contact info for 250,000+ industry contacts (includes email & direct phone)
  

Global Drug Development Activities
Our data and information allows you to research the investigational drug universe and to monitor daily changes and updates globally on the drugs and companies driving the industry.

200,000 Key Decision-Makers
Full, in-depth analysis on over 200,000 key decision-makers who are actively involved with clinical trials. Get the details on drug program and compliance managers, business development executives, clinicians, regulatory and compliance personnel — spanning R&D, management, and sales and marketing departments. View their email addresses and read their biographies. We also offer the names and contact detail of key opinion leaders who may offer advice on specific drug programs and companies.

220,000 Research Contacts
Complete list of all research contacts at biotech and pharmaceutical companies that have published a scientific article in the last five years. 100% of these contacts have a valid email address. This section of our service is invaluable for prospects interested in early stage development groups.

Drug Licensing Deals
Through our global network of journalists and research analysts, we provide up-to-date information and coverage of drug licensing deals as they take place. Search and screen through our database or utilize the Pharmawire journalism to keep tabs on the deals that are most important to you.

• Details on over 2,000 individual drug licensing deals
• Analysis of the deal including breakouts of terms
• Benchmarks for licensing deals, royalty rates, and milestone payments
• Alerts you to deals before they are announced

Drug Forecasts to 2018 -- Updated Daily
With information provided by leading investment banks and research analysts, BioPharm Insight provides actual and projected consensus sales information on over 3,000 drug products — both approved and pipeline. It provides the research and insight you need to evaluate market opportunities, analyze generic threats, and make mission critical strategic business decisions including…

• Therapeutic market sizing and growth projections
• Detailed searching capabilities on therapeutic area, company, mechanism and more
• Regional forecasts to size opportunities by different global areas
• Daily upgrades and downgrades that can be emailed to you based on your specific needs
• Full access to clinical and development history for forecasted drugs
• Prescription database covering 500 million prescriptions on over 20,000 drug programs